These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
131 related items for PubMed ID: 20098297
1. p63 Immunohistochemistry is a useful adjunct in distinguishing sclerosing cutaneous tumors. Vidal CI, Goldberg M, Burstein DE, Emanuel HJ, Emanuel PO. Am J Dermatopathol; 2010 May; 32(3):257-261. PubMed ID: 20098297 [Abstract] [Full Text] [Related]
2. Microcystic adnexal carcinoma: an immunohistochemical study including markers of proliferation and apoptosis. Smith KJ, Williams J, Corbett D, Skelton H. Am J Surg Pathol; 2001 Apr; 25(4):464-71. PubMed ID: 11257620 [Abstract] [Full Text] [Related]
3. Microcystic adnexal carcinoma: an immunohistochemical reappraisal. Hoang MP, Dresser KA, Kapur P, High WA, Mahalingam M. Mod Pathol; 2008 Feb; 21(2):178-85. PubMed ID: 18065959 [Abstract] [Full Text] [Related]
4. The immunohistochemical differential diagnosis of microcystic adnexal carcinoma, desmoplastic trichoepithelioma and morpheaform basal cell carcinoma using BerEP4 and stem cell markers. Sellheyer K, Nelson P, Kutzner H, Patel RM. J Cutan Pathol; 2013 Apr; 40(4):363-70. PubMed ID: 23398472 [Abstract] [Full Text] [Related]
5. Merkel cells and sclerosing epithelial neoplasms. Abesamis-Cubillan E, El-Shabrawi-Caelen L, LeBoit PE. Am J Dermatopathol; 2000 Aug; 22(4):311-5. PubMed ID: 10949455 [Abstract] [Full Text] [Related]
7. Does Immunohistochemistry Add to Morphology in Differentiating Trichoepithelioma, Desmoplastic Trichoepithelioma, Morpheaform Basal Cell Carcinoma, and Microcystic Adnexal Carcinoma? Mohanty SK, Sardana R, McFall M, Pradhan D, Usmani A, Jha S, Mishra SK, Sampat NY, Lobo A, Wu JM, Balzer BL, Frishberg DP. Appl Immunohistochem Mol Morphol; 2022 Apr 01; 30(4):273-277. PubMed ID: 35384877 [Abstract] [Full Text] [Related]
8. Morpheaform Basal Cell Carcinomas With Areas of Predominantly Single-Cell Pattern of Infiltration: Diagnostic Utility of p63 and Cytokeratin. East E, Fullen DR, Arps D, Patel RM, Palanisamy N, Carskadon S, Harms PW. Am J Dermatopathol; 2016 Oct 01; 38(10):744-50. PubMed ID: 27043336 [Abstract] [Full Text] [Related]
9. Ln-γ 2 chain of laminin-332 is a useful marker in differentiating between benign and malignant sclerosing adnexal neoplasms. Koga K, Anan T, Fukumoto T, Fujimoto M, Nabeshima K. Histopathology; 2020 Jan 01; 76(2):318-324. PubMed ID: 31429981 [Abstract] [Full Text] [Related]
10. Comparative analysis of cytokeratin 15, TDAG51, cytokeratin 20 and androgen receptor in sclerosing adnexal neoplasms and variants of basal cell carcinoma. Evangelista MT, North JP. J Cutan Pathol; 2015 Nov 01; 42(11):824-31. PubMed ID: 26016446 [Abstract] [Full Text] [Related]
11. Microcystic adnexal carcinoma versus desmoplastic trichoepithelioma: a comparative study. Tse JY, Nguyen AT, Le LP, Hoang MP. Am J Dermatopathol; 2013 Feb 01; 35(1):50-5. PubMed ID: 22722464 [Abstract] [Full Text] [Related]
12. Use of CD34 in assessing the relationship between stroma and tumor in desmoplastic keratinocytic neoplasms. Kirchmann TT, Prieto VG, Smoller BR. J Cutan Pathol; 1995 Oct 01; 22(5):422-6. PubMed ID: 8594074 [Abstract] [Full Text] [Related]
13. Role of CD10, wide-spectrum keratin, p63, and podoplanin in the distinction of epithelioid and spindle cell tumors of the skin: an immunohistochemical study of 81 cases. Buonaccorsi JN, Plaza JA. Am J Dermatopathol; 2012 Jun 01; 34(4):404-11. PubMed ID: 22257901 [Abstract] [Full Text] [Related]
14. Microcystic adnexal carcinoma. An immunohistochemical comparison with other cutaneous appendage tumors. Wick MR, Cooper PH, Swanson PE, Kaye VN, Sun TT. Arch Dermatol; 1990 Feb 01; 126(2):189-94. PubMed ID: 1689137 [Abstract] [Full Text] [Related]
15. Desmoplastic trichoepithelioma, infiltrative/morpheaform BCC, and microcystic adnexal carcinoma: differentiation by immunohistochemistry and determining the need for Mohs micrographic surgery. Merritt BG, Snow SN, Longley BJ. Cutis; 2010 May 01; 85(5):254-8. PubMed ID: 20540416 [Abstract] [Full Text] [Related]
16. Desmoplastic Trichoepithelioma: An Uncommon but Diagnostically Problematic Benign Adnexal Tumor. Bartoš V. Acta Dermatovenerol Croat; 2019 Dec 01; 27(4):282-284. PubMed ID: 31969246 [Abstract] [Full Text] [Related]
17. Desmoplastic trichoepithelioma versus morphoeic basal cell carcinoma: a critical reappraisal of histomorphological and immunohistochemical criteria for differentiation. Costache M, Bresch M, Böer A. Histopathology; 2008 Jun 01; 52(7):865-76. PubMed ID: 18462369 [Abstract] [Full Text] [Related]
18. Expression of p75 neurotrophin receptor in desmoplastic trichoepithelioma, infiltrative basal cell carcinoma, and microcystic adnexal carcinoma. Jedrych J, McNiff JM. Am J Dermatopathol; 2013 May 01; 35(3):308-15. PubMed ID: 23598854 [Abstract] [Full Text] [Related]
19. The diagnostic utility of immunohistochemistry in distinguishing primary skin adnexal carcinomas from metastatic adenocarcinoma to skin: an immunohistochemical reappraisal using cytokeratin 15, nestin, p63, D2-40, and calretinin. Mahalingam M, Nguyen LP, Richards JE, Muzikansky A, Hoang MP. Mod Pathol; 2010 May 01; 23(5):713-9. PubMed ID: 20190734 [Abstract] [Full Text] [Related]
20. Immunohistochemical distinction of invasive from noninvasive breast lesions: a comparative study of p63 versus calponin and smooth muscle myosin heavy chain. Werling RW, Hwang H, Yaziji H, Gown AM. Am J Surg Pathol; 2003 Jan 01; 27(1):82-90. PubMed ID: 12502930 [Abstract] [Full Text] [Related] Page: [Next] [New Search]